RE: Facts17 Oct 2025 08:49
Bonneville
I watched one of the interviews yesterday and from what i can take from that part was there are various groups withing a category and group M of said category is the biggest responder to P140 and so the diagnostics picks up on not only the group M of that specific category but those that will also respond well to P140 within group M , that's my take on that as an average take on it . Seems extremely targeted which is not a bad thing in terms of illness within autoimmune as it is just so broad , why pitch an average medication across the board that may or may not work when u can have a go to option for that specific illness . Lets be honest in most cases the patient spends so long waiting to be diagnosed with these illnesses that time is precious and you want treating asap and this could be the golden ticket to group m of category whatever and within a month your getting the correct treatment rather than lets try that then that and then that oh dear we are out of time patient didn't last . Sounds extreme but ive been there as a parent of a child watching and waiting firstly for diagnosis and then what product can we throw at this , lucky dip time coming up oh rubbish that didnt work. You can see where im going with this.
Have a great day all and as they say , you gotta be in it to win it